We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Long-Acting beta[sub2]-Agonist Monotherapy vs Continued Therapy With Inhaled Corticosteroids in Patients With Persistent Asthma.
- Authors
Lazarus, Stephen C.; Boushey, Homer A.; Fahy, John V.; Chinchilli, Vernon M.; Lemanske, Robert F.; Sorkness, Christine A.; Kraft, Monica; Fish, James E.; Peters, Stephen P.; Craig, Timothy; Drazen, Jeffrey M.; Ford, Jean G.; Israel, Elliot; Martin, Richard J.; Mauger, Elizabeth A.; Nachman, Sami A.; Spahn, Joseph D.; Szefler, Stanley J.
- Abstract
Reports on a study which examined the effectiveness of salmeterol xinafoate, a long-acting beta[sub2]-agonist, as replacement therapy in patients whose asthma is well controlled by low dose triamcinolone acetonide, an inhaled corticosteroid. Design and setting; Participants; Interventions; Main outcome measures; Results; Conclusion.
- Subjects
ASTHMA treatment; ADRENERGIC beta agonists; CORTICOSTEROIDS; ASTHMATICS
- Publication
JAMA: Journal of the American Medical Association, 2001, Vol 285, Issue 20, p2583
- ISSN
0098-7484
- Publication type
Article
- DOI
10.1001/jama.285.20.2583